A new bioinformatics tool to help assess the significance of BRCA1 variants
Abstract Background Germline pathogenic variants in the breast cancer type 1 susceptibility gene BRCA1 are associated with a 60% lifetime risk for breast and ovarian cancer. This overall risk estimate is for all BRCA1 variants; obviously, not all variants confer the same risk of developing a disease...
Main Authors: | Isabelle Cusin, Daniel Teixeira, Monique Zahn-Zabal, Valentine Rech de Laval, Anne Gleizes, Valeria Viassolo, Pierre O. Chappuis, Pierre Hutter, Amos Bairoch, Pascale Gaudet |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-07-01
|
Series: | Human Genomics |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s40246-018-0168-0 |
Similar Items
-
Prostate Cancer: Germline Mutations in BRCA1 and BRCA2
by: Pankaja Umarane, et al.
Published: (2023-03-01) -
BRCA Testing in Serbia and Montenegro
by: Brankovic-Magic Mirjana
Published: (2006-10-01) -
Turkish population-based screening for first identified changes of BRCA1 and BRCA2 genes in breast and/or ovarian cancer patients
by: Tuğba Semerci Sevimli, et al.
Published: (2024-04-01) -
BRCA1 and BRCA2 mutations in Iranian breast cancer patients: A systematic review
by: Hossein Neamatzadeh, et al.
Published: (2015-01-01) -
The Role of Hormonal Replacement Therapy in BRCA Mutated Patients: Lights and Shadows
by: Vera Loizzi, et al.
Published: (2023-01-01)